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a b s t r a c tIntestinal transplantation (ITx) is often associated with decreased abdominal domain, rendering abdominal clo-
sure difﬁcult. Pre-transplant placement of tissue expanders (TE) can overcome this challenge; however it can be
associated with life-threatening complications. This review aimed to comprehensively summarize all available
literature on TE in ITx candidates and include the technical details of osmotic, self-inﬂatable TE -a technique
undescribed before. PubMed, EMBASE and CCTRwere searched until April 30, 2016. Based on structured data ab-
straction and detailed analysis, eighteen cases of TE (inﬂatable) in ITx candidates were found. Localisation of
placement was: subcutaneously in 11; intraperitoneally in 4; 1 patient had 1 TE placed retromuscularly and 1 in-
traperitoneally; 1 patient had biplanar TE (intraperitoneally placed and extending retromuscularly) and in 1
localisation was unreported. Complication rate was high (61%), injection- or intraperitoneal-related, resulting
in life-threatening infections/hematoma. With successful expansion, physiological graft protection -by
skin+/−fascia-was always achieved. In completion of this review,wedescribe our own experiencewith two pa-
tients (7.5-, 34-year-old females), in whom osmotic TEwere placed subcutaneously pre-ITx. No TE-related com-
plications occurred and both patients underwent uncomplicated ITx with respectively primary skin and skin +
fascia closure. The pros and cons of each TE type and placement are discussed, resulting in the overall conclusions
that TE offer an important beneﬁt in graft-protection following ITx. Osmotic TE are safer than conventional pros-
theses by avoiding percutaneous injections. Subcutaneous placement seems to be safer and more reliable.
© 2016 Elsevier Inc. All rights reserved.1. Introduction
Intestinal transplantation (ITx) is the least common form of organ
transplantation and often deemed one of themost difﬁcult. It is only of-
fered to selected patients with chronic intestinal failure -like short
bowel syndrome (SBS)- and life-threatening complications of nutrition-
al support such as impaired venous access, recurrent infections and liver
failure [1,2]. Patients with a SBS after (repetitive) surgical resection of
the entire small bowel often present with an impaired abdominal skin
and fascia elasticity and markedly decreased intra-abdominal domain,
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(2016), http://dx.doi.org/10.1016/j.trre.2016.07.002edema of the graft and the recipient. All these factors render abdominal
closure after ITx extremely challenging, in particular in children [3,4].
However, successful closure in this mostly very ill and highly immuno-
suppressed population has proven to be essential to decrease the risk of
infections, ﬁstulisations and mycotic aneurysms and to improve graft
and patient survival [5,6]. Although the preferred donor to recipient
weight ratio (DRWR) should be lower than 1 to increase the possibility
of primary abdominal closure, very few small size donors are available
[7]. This critical shortage of size-matched organs, particularly for infants
in need of combined liver-intestinal transplantation (cLi-ITx), has led to
long waiting times and pre-transplant mortality rates up to 50% [8]. In
order to transplant larger grafts and expand the donor pool, several
techniques have been developed, like surgical reduction of the
graft, intra-operative bridging of the abdominal fascia (with synthetic/
biological meshes or cadaveric donor grafts), component separation
techniques, rotation/free ﬂap coverage and even abdominal wall trans-
plantation [4,9–12].
Pre-transplant placement of inﬂatable tissue expanders (TE) has
only been reported in a few cases [13–18]. They offer the potential ben-
eﬁt to increase the abdominal domain pre-ITx and provide sufﬁcient
skin and/or fascia resulting in physiological graft protection without
the aid of foreignmaterial. However, serial percutaneousﬂuid injectionsble tissue expanders in intestinal transplant candidates, Transplant Rev
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or hematoma. This review aimed (i) to comprehensively summarize
all available literature on TE in ITx candidates and (ii) to report
our own experience with two cases in which osmotic self-inﬂatable
TE were used -a technique undescribed before- which has the
major beneﬁt of avoiding serial percutaneous injections and its associat-
ed complications.
2. Materials and methods
2.1. Study selection
To identify papers relevant to the role of TE in ITx, a literature search
of three major electronic databases –MEDLINE (via PubMed), EMBASE
and Cochrane Controlled Trial Reports –was conducted until April 30th,
2016, based on three concepts: 1) Transplantation; 2) Intestine; and
3) TE or abdominal wound closure techniques. Study inclusion criteria
were: original papers reporting TE in ITx candidates; quantitative or
qualitative studies; literature written in English, Dutch, French or Ger-
man. Exclusion criteria were: abstracts, editorials and opinions. Two re-
viewers (LJC and NPD) screened all titles and abstracts independently
for eligibility and cross-checked the references of the included papers.
2.2. Data extraction
Data extraction included information on the author, year of publica-
tion, patient age, time of TE placement, type of ITx, donor-recipient
weight ratio (DRWR), number of TE, total volume of TE, localisation
(subcutaneously, retromuscular or intraperitoneally), type of TE (inﬂat-
able or osmotic), TE-related complications, number of removed TE and
successful primary abdominal closure after ITx. Data were extracted in-
dependently by two researchers (LJC and NPD) and tabulated descrip-
tively using Microsoft Excel® (Microsoft Ofﬁce 2013).
Based on a detailed analysis of all reported cases, we discuss the pros
and cons of each TE type and placement.
2.3. New technique of osmotic tissue expanders
In addition to the reported cases in literature, we added our experi-
ence, in which we used osmotic TE (OsmedGmbh, Ilmenau, Germany)
that were inserted subcutaneously via small incisions – a technique
undescribed before. Although this placement would only result in skin
expansion without enlarging the abdominal fascia, it was considered
the safest technique that would offer immediate graft protection post-
ITx and thatwould avoid serial percutaneous injections and its associat-
ed complications. Informed consent of the patient or the responsible
parent was obtained. Once implanted, the dehydrated hydrogel ex-
panded by absorbing body ﬂuid in the ﬁrst 6–8 weeks, leading to grad-
ual expansion of the skin without the need for external ﬂuid injection.
To avoid overexpansion, TE were self-limiting in size.
3. Results
3.1. Descriptive analysis
Six papers were ﬁnally included of which data abstraction is report-
ed in detail in Table 1[13–18].
The use of TE prior to ITxwas ﬁrst reported by de Ville de Goyet et al.
in 2000 [13]. In an 18 month-old child (9.8 kg) with short gut and tight
abdomen, insertion of a preperitoneally placed (no other localisation
details were provided) inﬂatable TE allowed sufﬁcient abdominal ex-
pansion.Waiting time after implantation was 3months and a surgically
reduced cLi-ITx graft from a larger donor (12 years of age; 35 kg; DRWR:
3.6) could be transplanted with primary skin and fascia closure.
In the same year, Alexandrides et al. reported on a 19 year-old male
in whom 2 inﬂatable TE were inserted intraperitoneally [14]. However,Please cite this article as: Ceulemans LJ, et al, The role of osmotic self-inﬂata
(2016), http://dx.doi.org/10.1016/j.trre.2016.07.002the patient developed TE-related peritonitis and the expanders had to
be removed 18 days later.
In 2008, Marin-Gutzke et al. described the combined placement of
an intraperitoneal (1000 cm3) and retromuscular (700 cm3) prosthesis
with subcutaneous ports for percutaneous inﬂation in a 27-year-old pa-
tient awaiting isolated ITx [15]. Increase of the abdominal cavity was re-
quired after total small bowel resection for an abdominal desmoid
tumor. One month after insertion, expansion was completed and 4
months later ITx could be performed uneventfully. The patient tolerated
the TE without complications and the abdominal cavity created was
large enough to accommodate the bowel. Tension-free fascia closure
could be achieved.
In 2013,Watson et al. reported on theCleveland experience inwhich
9 inﬂatable TEwere inserted subcutaneously in 4 adult patients [16]. Al-
though the second patient lost 1 of his 3 expanders due to port-related
dysfunction, primary abdominal closure could be obtained (no details
on skin or fascia closurewere provided). In 2 other patients primary ab-
dominal closure could be achieved, reported as skin closure in combina-
tionwith anAllodermmesh to bridge the fascia in theﬁrst and both skin
and fascia closure in the second patient. The fourth patient of this cohort
was still on the waiting list at the time of report.
Vidyadharan et al. described in 2013 the Birmingham experience in
which 7 children awaiting cLi-ITx received 17 subcutaneously placed in-
ﬂatable TE [17]. Although the volume of each expander was reported,
this could not be linked to the patient, resulting in an overall mean vol-
ume of 278 cm3/TE. All patients suffered from TE-related complications
and 1 patient died from a TE injection-related infection. Two other pa-
tients died before transplantation (TE-unrelated). All 4 survivors
underwent a reduced cLi-ITx, and required staged abdominal closure.
No further details were provided. In the discussion of the paper the
authors reported their experience with intraperitoneal placement
of TE in 3 additional patients (the number of TE was not described).
Two of them developed hematoma and 1 compression of the inferior
caval vein.
Weiner et al. introduced in 2014 in a 34 month-old child –with SBS
due to volvulus – the use of 2 biplanar TE, intraperitoneally placed and
extending retromuscularly into the chest wall and groin, respectively
[18]. Serial injections over 3 months, resulted in a tolerated expansion
of 230 and 345 cm3. Ten months after placement, the patient
underwent a successful isolated ITx. Although DRWR was limited to
0.9, post-reperfusion edema of the graft required temporarily closure
of the abdominal wall with a Gore-Texmesh for 7 days, after which fas-
cia closure could be obtained. The extension of the biplanar TE into
retromuscular pockets allowed the TE to be supported and anchored
by stable skeletal structures (ribs and iliac crest) minimizing the risk
of migration and redirecting the force of expansion outward. The latter,
hypothetically, avoided pressure on the peritoneal content.
3.2. Osmotic tissue expanders
The ﬁrst patient in our own experience was a 7,5 year-old girl, who
suffered from a neonatal volvulus, requiring repeated surgical resec-
tions of the small bowel and ascending colon leaving her with an ultra-
short bowel and duodenostomy. She was completely dependent on
total parenteral nutrition and gradually developed liver cirrhosis with
portal hypertension and hemorrhagic gastro- and duodenopathy. The
only remaining optionwas cLi-ITx. In order to have the possibility to ac-
cept larger grafts and offer immediate physiological graft protection
post-ITx, three TE were inserted subcutaneously: the ﬁrst (450 cm3)
in the right hypochondrium; the second (300 cm3) in the left
hypochondrium – adjacent to the stoma; and the third (600 cm3) in
the right fossa (Fig. 1A1). Although the operation was uneventful, the
left TE had to be removed two days later due to stoma-bag application
difﬁculties. The remaining TE reached their maximum volume and no
other complications occurred. 18 months later (weight: 25 kg) the pa-
tient underwent cLi-ITx from a 9-year-old male deceased donorble tissue expanders in intestinal transplant candidates, Transplant Rev
Table 1
Literature review on tissue expanders in intestinal transplantation.
Author Year Patient age Time
pre- Tx
Type Tx DRWR† TE+ Total volume (cc) Localization TE Type TE:
Inﬂatable/Osmotic
TE
compli-cations
TE removed Primary abdominal closure:
Yes/No, Skin/Fascia
de Ville de
Goyet
2000 1y 6mo 3mo c Li-ITx⁎ (reduced graft) 3,6 1 220 Extraperitoneal Inﬂatable None 0 Yes, Skin + Fascia
Alexandrides 2000 19 y 1y 5mo MvTx† 1,8 2 450/250 Intraperitoneal Inﬂatable Inf§ 2 Yes, NA (TE removed)
Marin-Gutzke 2002 27y 5mo ITx‡ NA 2 1000/700 Intraperitoneal
(1) Retromuscular (1)
Inﬂatable None 0 Yes, Skin + Fascia
Watson 2013 32y 1y 6mo ITx NA 2 480/480 Subcutaneous Inﬂatable None 0 Yes, Skin (Fascia: Alloderm)
47y 5mo ITx NA 3 NA (1)/532/118 Subcutaneous Inﬂatable Port-related 1 Yes, NA
44y 2y 3mo Re-ITx NA 2 753/608 Subcutaneous Inﬂatable None 0 Yes, Skin + Fascia
56y / WL# / 2 545/746 Subcutaneous Inﬂatable None 0 /
Vidyadharan 2013 1y 3mo 5mo c Li-ITx (reduced graft) 2,6 3 mean:278/TE° Subcutaneous Inﬂatable Hem 0 NA
10mo 4mo c Li-ITx (reduced graft) 1,7 3 mean:278/TE Subcutaneous Inﬂatable Port-related 0 NA
11mo 6mo c Li-ITx (reduced graft) 1,5 2 mean:278/TE Subcutaneous Inﬂatable Hem/dehis^ 1 NA
11mo 1y 1mo c Li-ITx (reduced graft) 1,3 1 mean:278/TE Subcutaneous Inﬂatable Hem/dehis 0 NA
1y 2mo / Died on WL / 3 mean:278/TE Subcutaneous Inﬂatable Hem/dehis 1 /
1y 2mo / Died on WL / 3 mean:278/TE Subcutaneous Inﬂatable Hem/inf/death 1 /
1y 3mo / Died on WL / 2 mean:278/TE Subcutaneous Inﬂatable Hem 0 /
(discussion) NA¶ NA NA NA ≥1 NA Intraperitoneal Inﬂatable Hem NA NA
(discussion) NA NA NA NA ≥1 NA Intraperitoneal Inﬂatable Hem NA NA
(discussion) NA NA NA NA ≥1 NA Intraperitoneal Inﬂatable ICV£
compression
NA NA
Weiner 2014 2y 10mo 10mo ITx 0.9 2 230/345 Biplanar:
Intraperitoneal + Retromuscular
Inﬂatable None 0 Yes, Skin (Fascia: Gore-Tex)
Ceulemans 2015 7y 6mo 1y 5mo c Li-ITx 1,2 3 450/300/600 Subcutaneous Osmotic Stoma-related 1 Yes, Skin
34y 2mo ITx (Living) 1,2 2 400/400 Subcutaneous Osmotic None 0 Yes, Skin + Fascia
Median
(range)
2y 10mo
(10mo-56y)
6mo
(2mo-2y
3mo)
1.5
(0.9–3.6)
2
(1–3)
278 cm3/TE
(118-1000 cm3)
Total Patients: 20 Grafts: c Li-ITx: 6 ITx:
6MvTx: 1 Died/WL: 4
NA: 3
TE: ≥
41
Patients: Subcutaneous: 13
Intraperitoneal: 4
Retromuscular &
intraperitoneal: 1
Biplanar: 1
Extraperitoneal:1
Patients:
Inﬂatable: 18
Osmotic: 2
Patients:
13/20 (65%)
TE:
7/38
(18%)
Patients:
6/17 (35%)
Patients:
Yes: 9/9 (100%)
NA: 7
Died on WL: 3
WL: 1
Skin: 7/7 (100%)
Fascia: 4/7 (57%)
NA: 2
¶ Not available; ⁎ Combined liver and intestinal transplantation; †Multivisceral transplantation; ‡ Isolated Intestinal Transplantation; #Waiting list; † Donor recipient weight ratio; + Tissue expander; ° Paper reports the number and volume of tissue
expanders separate from the patient; § Infection; $ Hematoma; ^ Wound Dehiscence; £ Inferior Caval Vein.
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Fig. 1. Panel A: Illustrations of tissue expanders (TE) in patient 1 A1:Via a supra- and infra-umbilical incision, three TEwere inserted. One in the right hypochondrium (450 cm3), one in the
left hypochondium (300 cm3) and one in the right fossa (600 cm3) A2: Full expansion of the two remaining TE at the time of transplantation A3: Two TE created sufﬁcient expansion of the
skin which turned into a strong ﬁbrotic and well-vascularized structure Panel B: Illustrations of tissue expanders (TE) in patient 2 B1: Computed tomographic axial images showing two
subcutaneously placed TE B2: Full expansion of the two TE (400 cm3/TE) at the time of transplantation B3: Removed TE at the start of the transplant procedure B4: Primary skin and fascia
closure of the abdominal wall was achieved after transplantation.
4 L.J. Ceulemans et al. / Transplantation Reviews xxx (2016) xxx–xxx(weight: 30 kg) (DRWR: 1.2). Both TE were removed at the start of the
procedure. The prostheses had turned the skin into a strong ﬁbrotic
layer that easily enabled primary skin closure and complete graft cover-
age (Figs. 1A2 and A3). Due to post-reperfusion edema the fascia could
not be closed primarily butwas closed fourweeks later during a surgical
re-exploration for a prolapsed ileostomy. The patient was administered
a low-dose dual immunosuppressive regimen of tacrolimus and ste-
roids [19]. No herniation or other skin- or fascia-related complications
occurred and at last follow-up−7 years later- she was doing well.
Our second patient was a 34 year-old female (weight: 44 kg)
with isolated intestinal Churg-Strauss lesions requiring multiple
enterectomies resulting in an extreme SBS [20]. Parenteral nutrition re-
sulted in several line infections and ITx was considered the only life-
saving option. As the patient was a non-Eurotransplant resident
(Poland) and could not be listed for a cadaveric transplant, the onlyPlease cite this article as: Ceulemans LJ, et al, The role of osmotic self-inﬂata
(2016), http://dx.doi.org/10.1016/j.trre.2016.07.002remaining option was a living-related donation of two meters of distal
ileum. The patients' 59 year-old mother (weight: 52 kg; DRWR: 1.2)
was a suitable candidate. Since the abdominal domain in the recipient
was severely restricted, two TE (400 cm3/TE) were inserted subcutane-
ously in each hypochondrium twomonths prior to the planned ITx. Tis-
sue expansion was uncomplicated and since post-reperfusion edema
was limited, primary closure of the skin and fascia could be achieved
(Fig. 1B). No abdominal closure-related complications occurred, but
due to chronic rejection the graft had to be removed 7 months later.
3.3. Overall experience
With inclusion of our 2 patients reported herein, experience with at
least 41 TE in 20 ITx candidates has been reported. Median patient age
was 2 years 10 months (10 months–56 years) with a median timeble tissue expanders in intestinal transplant candidates, Transplant Rev
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months). Thirteen patients (65%) ﬁnally underwent transplantation (6
cLi-ITx, 6 isolated ITx and 1multivisceral Tx) of which 12were from de-
ceased donors and 1 from a living donor. Median DRWR was 1.5
(0.9–3.6). A median of 2 (1–3) TE/patient were placed with a median
volume/TE of 278 cm3 (118–1000 cm3). In 13 patients (65%) TE were
placed subcutaneously, 1 patient (5%) was treated with 1 TE placed
retromuscularly and 1 TE placed intraperitoneally, in 4 patients (20%)
TEwere only inserted intraperitoneally and in 1 case (5%) a biplanar (in-
traperitoneally placed and extending retromuscularly) TE was used. In
the ﬁrst case (5%) reported, TE were placed preperitoneally, without
any further details described. All patients required weekly serial percu-
taneous TE ﬂuid injections, apart from the 2 patients (10%) reported
herein who had osmotic self-inﬂatable prostheses. Of 18 patients in
whom inﬂatable TE were used, 11 patients (61%) suffered from TE-
related complications of which the most frequent were hematoma
and infection due to serial percutaneous injections with even one TE-
related death [17]. In the two cases of osmotic expanders, one expander
had to be removed due to stoma bag application problems, however no
infections or hematoma occurred. Overall TE-related complications oc-
curred in 4 out of 5 patients (80%) who received an intraperitoneally
placed TE and 9 out of 13 patients (69%) in whom TE were placed sub-
cutaneously. These side-effects resulted in removal of 7 TE from 6 pa-
tients before complete expansion was achieved.
In 9 out of 9 patients (100%) – for whom details on abdominal clo-
sure after ITx were reported- primary abdominal closure resulting in
graft protection could be obtained. In 2 cases, no details were given on
skin or fascia closure. Out of 7 cases, which made a distinction between
skin and fascia closure, 4 (57%) succeeded also in primary fascia closure.
In the other 3 cases, alternatives were bridging of the fascia with
Alloderm in 1, Gore-Tex in 1 and staged closure in 1. Two of the latter
3 occurred in patients with subcutaneously placed TE. Although num-
bers are small, this could be explained by the observation of Watson
et al. who revealed – by sequential volumetric computed tomography
– that with subcutaneous expansion, the increase in total abdominal
volume (delineated by the abdominal skin) was accompanied with a
25% compensatory intraperitoneal volume loss [16].
4. Discussion
Since the ﬁrst description by Byrd and Hobar in 1989, TE have suc-
cessfully been used in general, pediatric and plastic surgery for closure
of large abdominal fascia and skin defects such as omphalocele, long-
standing large abdominal hernias, separation of conjoined twins and re-
constructive surgery for extensive burns [21,22]. They can be inserted
subcutaneously (in front of the anterior rectus fascia), retromuscularly
(between the rectusmuscle and the posterior fascial sheet) or intraper-
itoneally (Fig. 2). Despite their versatility, TE have been associated with
signiﬁcant complications since inception. A general complication rate of
13–20% has been reported with infection, hematoma and device migra-
tion being the most frequent [22,23]. Experience of TE in patients
awaiting ITx is limited due to concerns related to the use of foreign ma-
terial in critically ill patients as well as space limitations caused by
ﬁstulisation, scar tissue and often a stoma.
This review summarizes the experience of 41 TE in 20 ITx candi-
dates. Many of them were children, since TE offer the potential beneﬁt
to accept larger grafts and increase the DRWR. An interesting difference
in most cases is the TE placement. Three major localisations were iden-
tiﬁed: intraperitoneally, retromuscular and subcutaneously (Fig. 2).
Although itwould seem logical to enlarge the abdominal fascia by in-
traperitoneally placed TE, this procedure requires more extensive sur-
gery than subcutaneous placement of TE and may potentially result in
more severe complications like peritonitis and compression of the
intra-abdominal organs. Interestingly, in case of successful intraperito-
neal TE placement, of which details of abdominal closure were only
available in 2 cases, 1 (50%) of them did not result in primary fasciaPlease cite this article as: Ceulemans LJ, et al, The role of osmotic self-inﬂata
(2016), http://dx.doi.org/10.1016/j.trre.2016.07.002closure. Subcutaneous placement in contrast is a relatively benign proce-
dure, does not violate the abdominal cavity, and can be performed with
low morbidity. Expansion is generally well tolerated, and large volume
increases can be achieved in a relatively short period of time [16]. More-
over, skin is more extensible than fascia and easier to stretch on top of
the edematous organs after reperfusion. In the event of a complication,
re-exploration of a subcutaneous pocket has signiﬁcantly lessmorbidity
compared to a laparotomy. The most crucial aspect in the mostly criti-
cally ill ITx patient population is to avoid an open abdomen post-
transplant and protect the graft, thereby avoiding electrolyte imbal-
ances and limiting the risk for infection. Therefore we would recom-
mend to place TE subcutaneously, providing graft protection at the
lowest risk for complications.
To close the fascia, other techniques like component separation or
donor fascia transplant can be performed in conjunction with primary
skin closure or as a staged procedure. The rationale behind staged clo-
sure is to await reperfusion edema to disappear and prevent abdominal
compartment syndrome due to tight fascial closure [6,24].
Currently, there is too little evidence on retromuscular placement of
TE. Theoretically this would enlarge the abdominal fascia and skin,
thereby avoiding intraperitoneal surgery-related complications. How-
ever, this procedure, might compromise the potential necessity to per-
form a component separation technique at a later stage.
Sincemost TE-related complicationswere due to serial injections for
TE inﬂationwe introduced herein the use of osmotic self-inﬂatable TE of
which the major beneﬁt is to avoid these percutaneous injections. Al-
though our experience is only based on two patients, it seems a safer
and more elegant alternative. However, it should be taken into account
that in contrast to the volume of inﬂatable TE -which can be adapted to
the tolerance level of the patient- osmotic expansion cannot be con-
trolled. In order to avoid pain and skin tears by overexpansion, an accu-
rate estimation of the maximum volume is crucial. Therefore we advise
to opt for relatively small volume osmotic TE (500 cm3) with a maxi-
mum of three per patient and adjusted to the location of the stoma
and previous incisions.
The limitations of this study are the limited number of cases and the
limited number of outcome parameters reported in some studies. Nev-
ertheless, TE might offer signiﬁcant beneﬁts to ITx candidates in whom
primary abdominal closure would be difﬁcult: (i) offering primary ab-
dominal closure and physiological protection of the graft; (ii) avoiding
extensive abdominal wall surgery or foreign material insertion peri-
transplant in a heavily immunosuppressed patient; and (iii) possibility
to accept a relatively larger graft, thereby shortening the waiting time
for transplantation. Like other abdominal closure techniques, TE bear
several potential disadvantages like: (i) prolonged waiting time before
transplantation due to placement and expansion; (ii) additional anes-
thesia exposure; (iii) poor healing of the created pockets in patients
under immunosuppression; and (iv) injection-related complications
with inﬂatable TE. Osmotic self-inﬂatable TE are safer by avoiding serial
percutaneous injections.
In the future, we hope that other centers will consider to use the
same technique of osmotic self-inﬂatable TE.We also believe that amul-
ticenter study on the topic of abdominalwall closurewould increase our
knowledge on the best closure technique for each patient.
5. Conclusion
Abdominal tissue expansion is advised for selected ITx candidates
with an impaired abdominal wall (skin and fascia) elasticity and limited
intra-abdominal domain. Subcutaneous expansion is the most elegant
solution and seems the safest option to provide complete skin coverage
of the graft, resulting in physiological protection even in the context of
large fascial defects. Apart from several beneﬁts, the reported complica-
tion rate with conventional inﬂatable TE is high. Our experience indi-
cates that osmotic self-inﬂatable TE offer a safer alternative, since they
avoid serial percutaneous injections and their associated complicationsble tissue expanders in intestinal transplant candidates, Transplant Rev
Fig. 2. Schematic cross section of the abdomen illustrating the localization option for placement of tissue expanders, with their corresponding beneﬁts and risks: i) Subcutaneous (between
skin and anterior rectus fascia); ii) Retromuscular (between rectus muscle and posterior rectus fascia); and iii) Intraperitoneal. (Illustration by Francesca Maione, MD).
6 L.J. Ceulemans et al. / Transplantation Reviews xxx (2016) xxx–xxxand discomfort, especially in children. Finally, successful expansionmay
allow the transplantation of larger grafts, thereby reducing the waiting
time and mortality on the waiting list of ITx candidates.
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